Literature DB >> 1701755

Factors influencing response to interferon in chronic hepatitis B: implications for Asian and western populations.

R P Perrillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1701755     DOI： 10.1002/hep.1840120626

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

1.  Distribution of hepatitis B virus genotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit.

Authors:  Takashi Moriya; Isamu K Kuramoto; Hiroshi Yoshizawa; Paul V Holland
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 2.  Treatment of chronic hepatitis B: new antiviral therapies.

Authors:  F Yao; R G Gish
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

Review 3.  Hepatitis B virus. New and evolving issues.

Authors:  B Yoffe; C A Noonan
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

Review 4.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

5.  The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B.

Authors:  Tin Nguyen; Paul Desmond; Stephen Locarnini
Journal:  Hepatol Int       Date:  2009-09-18       Impact factor: 6.047

6.  Low dose interferon alfa-2b for chronic hepatitis B in Asian countries.

Authors:  E Mauracher
Journal:  Gut       Date:  1993       Impact factor: 23.059

7.  Viral hepatitis and the surgeon.

Authors:  G Y Minuk; A J Cohen; N Assy; M Moser
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

8.  Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa.

Authors:  Ijaz Ali; Lubna Siddique; Latif U Rehman; Najib U Khan; Aqib Iqbal; Iqbal Munir; Farzana Rashid; Sana U Khan; Safira Attache; Zahoor A Swati; Mehwish S Aslam
Journal:  Virol J       Date:  2011-06-11       Impact factor: 4.099
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.